NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens (U01) Clinical Trials Not Allowed
Agency: Food and Drug Administration
- 93.876 -- Antimicrobial Resistance Surveillance in Retail Food Specimens
Archived opportunityLast Updated: May 13, 2026
View version history on Grants.gov
Description
This Funding Opportunity Announcement (FOA) issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), builds upon the National Antimicrobial Resistance Monitoring System (NARMS) which was initiated in 1996 as one of the key activities in a national action plan to combat antibiotic resistance threats. The purpose of this FOA is to protect and promote public health by enhancing, strengthening and sustaining antibiotic resistance surveillance in retail food specimens within the NARMS program. The NARMS cooperative agreements is intended to improve the detection of antibiotic resistance among bacteria in food commodities, as well as expand to new sites to expand the scope of sampling. Measurable outcomes of the program will be in alignment with the NARMS Objectives.
Eligibility
Eligible applicants
Miscellaneous
- Other
Additional information
Grantor contact information
Description
rene.vasquez@fda.hhs.gov
Documents
No documents are currently available.
Link to additional information
--
Archived: May 26, 2021
Award
$--
Program Funding
50
Expected awards
$--
Award Minimum
$--
Award Maximum
Funding opportunity number:
FOR-FD-20-006
Cost sharing or matching requirement:
Funding instrument type:
Cooperative agreement
Opportunity Category:
Discretionary
Opportunity Category Explanation:
Category of Funding Activity:
Consumer protection
Food and nutrition
Agriculture
Category Explanation:
History
Version:
1
Posted date:
May 25, 2021
Archive date:
May 26, 2021
